Catalyst Wire Dossier Catalyst Wire Dossier

Velafermin

velafermin · CuraGen Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Velafermin, covering 2016-04-13 to 2016-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis [Phase 2]

See pricing